Authors:
Wichelhaus, TA
Schafer, V
Brade, V
Boddinghaus, B
Citation: Ta. Wichelhaus et al., Differential effect of rpoB mutations on antibacterial activities of rifampicin and KRM-1648 against Staphylococcus aureus, J ANTIMICRO, 47(2), 2001, pp. 153-156
Authors:
Boddinghaus, B
Wichelhaus, TA
Brade, V
Bittner, T
Citation: B. Boddinghaus et al., Removal of PCR inhibitors by silica membranes: Evaluating the amplicor Mycobacterium tuberculosis kit, J CLIN MICR, 39(10), 2001, pp. 3750-3752
Authors:
Sander, P
De Rossi, E
Boddinghaus, B
Cantoni, R
Branzoni, M
Bottger, EC
Takiff, H
Rodriquez, R
Lopez, G
Riccardi, G
Citation: P. Sander et al., Contribution of the multidrug efflux pump LfrA to innate mycobacterial drug resistance, FEMS MICROB, 193(1), 2000, pp. 19-23
Authors:
Wichelhaus, TA
Schafer, V
Brade, V
Boddinghaus, B
Citation: Ta. Wichelhaus et al., Molecular characterization of rpoB mutations conferring cross-resistance to rifamycins on methicillin-resistant Staphylococcus aureus, ANTIM AG CH, 43(11), 1999, pp. 2813-2816